Share on LinkedInShare on LinkedIn

ARTICLE · 12 SEPTEMBER 2013

The Trickle-Down Effect Of Product Patent In India And On The Developing World

S&A Law Offices
S&A Law Offices
Contributor
S&A Law Offices

S&A Law Offices

S&A Law Offices is a full-service law firm headquartered in Delhi NCR. The firm has 300+...

View firm profile
Explore more from S&A Law Offices

The Indian Patent Regime has been instrumental for the development of the Indian Generic drugs industry, making possible the production and availability of essential drugs at affordable prices.

IndiaIntellectual Property

Article by Kailash Choudhary and Ritiraj 1

The Indian Patent Regime has been instrumental for the development of the Indian Generic drugs industry, making possible the production and availability of essential drugs at affordable prices. Prior to the WTO and TRIPS the two distinct features of the Indian Patents Act, 1970, i.e. allowing only for process patent and not product patent by virtue of Section 5 of the Indian Patents Act, 1970, are the major factors for the growth of generic industry. The then act was prepared keeping in mind the socio-econimic condition of the country and was largely based on the recommendations of a report of a Ayyangar commission.

The growth of generic pharmaceutical industry due to the favorable patent regime not only had impact in India but also well beyond its borders. India is the main supplier of essential medicines for developing countries. As per the Annual Supply Report of UNICEF, India was the largest supplier country in 2012.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from